BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 1185 | Download: 1944
 |
Received |
|
2014-02-25 20:28 |
 |
Peer-Review Started |
|
2014-02-25 21:31 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-04-12 06:48 |
 |
Revised |
|
2014-05-25 07:54 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-07-25 09:25 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-07-25 09:51 |
 |
Articles in Press |
|
2014-07-25 09:55 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-30 15:09 |
 |
Publish the Manuscript Online |
|
2014-11-17 15:12 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jeong Tae Kim, Hye Won Jeong, Ki Hwa Choi, Tae Young Yoon, Nohyun Sung, Young Ki Choi, Eun Ha Kim and Hee Bok Chae |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chungbuk National University Hospital (2013) |
|
|
| Corresponding Author |
Hee Bok Chae, MD, Department of Internal Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, 52 Naesudong-ro, Heungdeok-gu, Cheongju 361-711, South Korea. hbhcae@chungbuk.ac.kr |
| Key Words |
Entecavir; Delayed type hypersensitivity; Maculopapular drug eruption; Dermatology; Adverse drug reaction; Chronic hepatitis B |
| Core Tip |
A potent efficacy and good overall safety profile has supported the rapid establishment of entecavir as a frequently prescribed antiviral nucleoside for treatment of chronic hepatitis B (CHB). Among the adverse drug reactions that have been reported in CHB patients, allergic dermatitis is especially rare, with only two cases in the literature to date. This report describes a pathologically and immunologically evidenced case of entecavir (ETV)-induced type Ⅳ delayed hypersensitivity reaction, which resolved upon ETV withdrawal. |
| Publish Date |
2014-11-17 15:12 |
| Citation |
Kim JT, Jeong HW, Choi KH, Yoon TY, Sung N, Choi YK, Kim EH, Chai HB. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B. World J Gastroenterol 2014; 20(42): 15931-15936 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i42/15931.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i42.15931 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.